NEWS
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Zhenwei Peng
Sun Yat Sen University - Guangzhou / China
Others
AD Scientific Index ID: 718650
太阳森大学
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Zhenwei Peng's MOST POPULAR ARTICLES
1-)
Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trialZW Peng, YJ Zhang, MS Chen, L Xu, HH Liang, XJ Lin, RP Guo, ...Journal of clinical oncology 31 (4), 426-432, 20135092013
2-)
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative studyZW Peng, XJ Lin, YJ Zhang, HH Liang, RP Guo, M Shi, MS ChenRadiology 262 (3), 1022-1033, 20122562012
3-)
Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH)Z Peng, W Fan, B Zhu, G Wang, J Sun, C Xiao, F Huang, R Tang, ...Journal of Clinical Oncology 41 (1), 117-127, 20232842023
4-)
Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversalN Ikenaga, ZW Peng, KA Vaid, SB Liu, S Yoshida, DY Sverdlov, ...Gut 66 (9), 1697-1708, 20172742017
5-)
Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trialZW Peng, YJ Zhang, HH Liang, XJ Lin, RP Guo, MS ChenRadiology 262 (2), 689-700, 20122612012
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept